Cited by 287Drug Transport and Resistance MechanismsCancer, Hypoxia, and MetabolismPharmacogenetics and Drug Metabolism

Regulation of the multidrug resistance transporter P‐glycoprotein in multicellular tumor spheroids by hypoxia‐inducible factor‐1 and reactive oxygen species

Wartenberg, Maria, Ling, Frederike C., Müschen, Markus, Klein, Florian, Acker, Helmut, Gassmann, Max, Petrat, Kerstin, Pütz, Volker +2 more·2003·The FASEB Journal

Abstract

Hypoxia in tumors is generally associated with chemoresistance and radioresistance. However, the correlation between the heterodimeric hypoxia-inducible factor-1 (HIF-1) and the multidrug resistance transporter P-glycoprotein (P-gp) has not been investigated. Herein, we demonstrate that with increasing size of DU-145 prostate multicellular tumor spheroids the pericellular oxygen pressure and the generation of reactive oxygen species decreased, whereas the alpha-subunit of HIF-1 (HIF-1alpha) and P-gp were up-regulated. Furthermore, P-gp was up-regulated under experimental physiological hypoxia and chemical hypoxia induced by either cobalt chloride or desferrioxamine. The pro-oxidants H2O2 and buthionine sulfoximine down-regulated HIF-1alpha and P-gp, whereas up-regulation was achieved with the radical scavengers dehydroascorbate, N-acetylcysteine, and vitamin E. The correlation of HIF-1alpha and P-gp expression was validated by the use of hepatoma tumor spheroids that were either wild type (Hepa1) or mutant (Hepa1C4) for aryl hydrocarbon receptor nuclear translocator (ARNT), i.e., HIF-1beta. Chemical hypoxia robustly increased HIF-1alpha as well as P-gp expression in Hepa1 tumor spheroids, whereas no changes were observed in Hepa1C4 spheroids. Hence, our data demonstrate that expression of P-gp in multicellular tumor spheroids is under the control of HIF-1.

Integrity signals

Registry

Crossref · 10.1096/fj.02-0358fje

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Interventions that alter mitochondrial function, translation, or proteostasis may either suppress or enhance HIF signaling depending on the prevailing redox-oxygen context, a phenomenon not predictable from oxygen availability alone.

    “Interventions that alter mitochondrial function, translation, or proteostasis may either suppress or enhance HIF signaling depending on the prevailing redox–oxygen context, a phenomenon not predictable from oxygen availability alone.”

    From HIF inhibition: Current strategies and clinical challenges (2026) · cites this paper as [215]

The citation lists haven’t been fetched yet

References 65 · Cited by 287

Authors
Wartenberg, M., Ling, F. C., Müschen, M., Klein, F., Acker, H., Gassmann, M., Petrat, K., Pütz, V., Hescheler, J., & Sauer, H.
Affiliations
  • University of Cologne (DE)
  • Max Planck Society (DE)
  • University of Zurich (CH)
Venue
The FASEB Journal
Publisher
Wiley
Published
2003-01-02
Volume
17
Issue
3
Pages
1-22
ISSN
  • 0892-6638 (ISSN-L)
  • 1530-6860
OpenAlex
W2122637273
Cited by
287
References
65
Citations by year
2026: 5 · 2025: 5 · 2024: 9 · 2023: 12 · 2022: 11 · 2021: 19 · 2020: 18 · 2019: 13 · 2018: 16 · 2017: 15 · 2016: 15 · 2015: 17 · 2014: 12 · 2013: 17 · 2012: 5
FWCI
5.86
Type
journal article
Language
en
Open access
closed
Locations
  • The FASEB Journal (publishedVersion)
  • PubMed (publishedVersion)
  • Max Planck Institute for Plasma Physics (submittedVersion)
  • MPG.PuRe (Max Planck Society) (submittedVersion)
Funders
Deutsche Forschungsgemeinschaft
Topics
  • Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacogenetics and Drug Metabolism
Keywords
P-glycoprotein, multidrug resistance, HIF-1, HIF-1α, reactive oxygen species, tumor spheroids, tumor hypoxia, chemoresistance, cobalt chloride, deferoxamine, ARNT, prostate cancer, hepatocellular carcinoma
MeSH terms
DNA-Binding Proteins, Carcinoma, Hepatocellular, Humans, Models, Biological, Mutation, Neoplasms, Oxidation-Reduction, Transcription Factors, Cell Hypoxia, Up-Regulation, Reactive Oxygen Species, Receptors, Aryl Hydrocarbon, Drug Resistance, Multiple, Spheroids, Cellular, Drug Resistance, Neoplasm, ATP Binding Cassette Transporter, Subfamily B, Member 1, Aryl Hydrocarbon Receptor Nuclear Translocator, Hypoxia-Inducible Factor 1, alpha Subunit

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review